Ticker ADVM – Adverum Biotechn – sales, description, marketcap – Tickerday.com

ADVM

Adverum Biotechn

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 993.25M; Volume: 133.86K; AvgVol 3m: 1.28M; Beta: 1.68;

Cost estimate:

P/E: –; EPS: -1.21; EPS growth quarter/prev quarter: -55.10%;

EPS growth this year: 15.00%; EPS growth past 5 years: 16.40%;

EPS ttm: -1.22;

P/S: 3509.34; P/B: 2.94; P/Cashflow: 3.76; P/FCF: ;

Sales: 250.00K; Sales growth quarter/prev quarter: ; Sales growth past 5 years: -15.30%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -31.50%; ROE – return on equity: -37.70%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.40%; Insider Transactions:-21.16%;

Institutional Ownership: 86.10%; Institutional Transactions: 1.29%;

Data update: 07.10.2020.